Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
Upgrades 2025 full-year CDMO sales and margin outlook
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
These medicines are essential in preventing RhD immunisation during pregnancy
Subscribe To Our Newsletter & Stay Updated